Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial

Ulrike Leiter, Rudolf Stadler, Cornelia Mauch, +15

The Lancet Oncology

Surgical OncologyMedicineSurgical PathologyMelanomaSurgery +5

Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial

Alexander Eggermont, Christian U. Blank, Mario Mandalà, +127

The Lancet Oncology

Surgical OncologyMedicineMelanomaImmunologyImmune Checkpoint Inhibitor +6

The LIFE-Adult-Study: objectives and design of a population-based cohort study with 10,000 deeply phenotyped adults in Germany

Markus Loeffler, Christoph Engel, Peter Ahnert, +54

BMC Public Health

Adjuvant nivolumab plus ipilimumab or nivolumab monotherapy versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): a randomised, double-blind, placebo-controlled, phase 2 trial

Lisa Zimmer, Elisabeth Livingstone, Jessica C. Hassel, +28

The Lancet

Surgical OncologyOncologyMelanomaImmunologyClinical Trials +4

Final Analysis of DeCOG-SLT Trial: No Survival Benefit for Complete Lymph Node Dissection in Patients With Melanoma With Positive Sentinel Node

Ulrike Leiter, Rudolf Stadler, Cornelia Mauch, +16

Journal of Clinical Oncology

Instructing Human Macrophage Polarization by Stiffness and Glycosaminoglycan Functionalization in 3D Collagen Networks

Markus Friedemann, Liv Kalbitzer, Sandra Franz, +4

Advanced Healthcare Materials

Tissue EngineeringEngineeringBiomimetic MaterialsHuman Macrophage PolarizationMph Polarization +26

Adjuvant nivolumab plus ipilimumab or nivolumab alone versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): final results of a randomised, double-blind, phase 2 trial

Elisabeth Livingstone, Lisa Zimmer, Jessica C. Hassel, +53

The Lancet

Surgical OncologyMedicineMelanomaImmunologyClinical Trials +5

The aromatic volatile organic compounds toluene, benzene and styrene induce COX-2 and prostaglandins in human lung epithelial cells via oxidative stress and p38 MAPK activation

Iljana Mögel, Sven Baumann, Alexander Böhme, +4

Toxicology

InflammationRespiratory ToxicologyMedicineLipid PeroxidationCell Death +7

Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): health-related quality-of-life results from a double-blind, randomised, controlled, phase 3 trial

Andrew Bottomley, Corneel Coens, Justyna Mierzynska, +129

The Lancet Oncology

Health-related Quality-of-life ResultsSurgical OncologyOncologyMelanomaImmunology +7

Chlorobenzene induces oxidative stress in human lung epithelial cells in vitro

Ralph Feltens, Iljana Mögel, Carmen Röder‐Stolinski, +3

Toxicology and Applied Pharmacology

AsthmaLung InflammationMedicineRespiratory ToxicologyPhysiology +6